Treatment of Varicose Veins by Foam Sclerotherapy Ultrasound-guided

Hospital Universitário da Universidade Federal de Sergipe0 个研究点开始时间: 2016年8月3日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Aged between 18 and 60 years inclusive. Male and female sex. Informed consent authorization. Reflux diagnosed by Doppler ultrasound in any saphenous vein extension and / or trunk varicose veins measuring between 4 and 8mm in diameter inclusive. Varicose veins classified APEC 3,4,5 and 6. Body mass index (BMI) between 25 and 40kg/m2.

•Patient with psychiatric disorder or limitation in the technique compreendimento. Women during pregnancy or risk pregnancy (without effective contraception) or nursing. Patients with a personal history of deep vein thrombosis and / or PET. Patients with known allergy to Polidocanol (synonyms: Lauromacrogol 400, macrogollauryleter, PEG9lauryl-alcohol). Patients with severe or chronic decompensated (hepatic insufficiency, renal insufficiency, CHF, COPD, respiratory insufficiency, progressive, malignant disease, hypertension and / or diabetes mellitus uncompensated). Intra-atrial or ventricular septal defect diagnosed by echocardiography. Closing of / attend the scheduled follow-ups. Patients who have Peripheral Arterial Disease Installed (ankle-brachial index less than 0, 9)

发起方

Hospital Universitário da Universidade Federal de Sergipe